Global Leaders in Pharmaceutical Research to Headline InnoPharm 2026 in Boston

Hybrid conference to feature renowned experts from Harvard, Stanford, Yale, UC San Diego, NIH, and other leading institutions. 

The Second International Conference on Innovations in Pharma R&D (InnoPharm 2026) is set to bring together an outstanding lineup of internationally recognized scientists, clinicians, and innovators from November 2–4, 2026, at the Holiday Inn Boston Hotel, Massachusetts, USA. Hosted in a hybrid format, the conference will welcome participants both in person and virtually, fostering global collaboration across academia, industry, healthcare, and regulatory science.

This year's plenary and keynote program features distinguished researchers from some of the world's most prestigious institutions, including:

• Donald E. Ingber, Founding Director & Core Faculty, Wyss Institute at Harvard University
• Daria Mochly-Rosen, Stanford University
• Martin Schwartz, Yale School of Medicine
• A. Thomas Look, Dana-Farber Cancer Institute, Harvard Medical School
• Rhoda Alani, Brigham and Women's Hospital, Harvard Medical School
• Paul A. Insel, University of California San Diego
• Ruben Abagyan, University of California San Diego
• Wolfgang Sadee, University of California San Francisco & Chief Scientific Officer, Aether Therapeutics
• Debbie C. Crans, Colorado State University
• Liwu Li, Virginia Polytechnic Institute and State University (Virginia Tech)

The conference will also feature distinguished virtual keynote presentations from:

• Joseph C. Wu, Stanford University
• Nathan D. Wong, University of California Irvine
• Ernst Wagner, Ludwig-Maximilians-Universität München, Germany
• Pal Pacher, National Institutes of Health (NIH)

Together, these globally respected experts will share insights into the latest advances in drug discovery and development, artificial intelligence in pharmaceutical research, precision medicine, drug delivery technologies, translational science, pharmacology, biotechnology, and emerging therapeutic strategies.

InnoPharm 2026 is designed to provide an international platform where researchers, pharmaceutical professionals, clinicians, biotechnology innovators, and students can exchange ideas, establish collaborations, and explore technologies that are shaping the future of medicine.

The hybrid format enables attendees from around the world to participate in scientific discussions, keynote lectures, technical sessions, networking events, and poster presentations, regardless of their location.

"As pharmaceutical research continues to evolve at an unprecedented pace, bringing together experts from diverse disciplines has never been more important. InnoPharm 2026 aims to create meaningful scientific dialogue that accelerates innovation and translates research into real-world healthcare solutions," said the conference organizing team.

Researchers and professionals are invited to join this global gathering and engage with leaders whose work continues to influence the future of pharmaceutical science.

Event Details

Event: Second International Conference on Innovations in Pharma R&D (InnoPharm 2026)
Dates: November 2–4, 2026
Venue: Holiday Inn Boston Hotel, Massachusetts, USA
Format: Hybrid (In-Person & Virtual)

Registration is now open.

Register: https://pharm-science.com/register

Contact:
Gayatri Srinivas
Conference Manager
InnoPharm-2026